eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search   

Medicine and the Media

Healthy Skepticism’s new AdWatch: understanding drug promotion

Peter R Mansfield
MJA 2003; 179 (11/12): 644-645
The AdWatch section of the Healthy Skepticism website (www.healthyskepticism.org/adwatch.asp) aims to improve medical decision-making by illuminating the techniques used in drug advertising. AdWatch draws on 20 years of dialogue about drug promotion plus ideas from many disciplines, especially logic, psychology and marketing.

A small group known as Healthy Skepticism . . . has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.1 Graham Dukes (Professor of Drug Policy Studies, University of Oslo, Norway)

The quality of care delivered by doctors and our consequent incomes depend on our decision-making skills in the face of information and promotion of variable quality. However, few doctors have much training in the basic sciences for decision-making, such as logic and psychology. A database of 2178 references on drug promotion compiled by the World Health Organization provides evidence that many doctors are more vulnerable to being misled than they realise.2

Healthy Skepticism is an international organisation based in Australia that aims to improve health by reducing harm from misleading drug promotion. In October 2003, Healthy Skepticism launched AdWatch, a monthly webpage that explains the techniques used in drug advertisements.3 The story of Healthy Skepticism’s predecessor, MaLAM (the Medical Lobby for Appropriate Marketing), was told in the 1997 Christmas issue of the Journal.4 This update describes the ideas behind the transition from MaLAM to Healthy Skepticism and the launch of AdWatch.

From MaLAM to Healthy Skepticism

In the 1980s, open letters from MaLAM achieved improvements in advertising and some drugs were withdrawn.5 During the 1990s, there were fewer obviously inappropriate drugs to target. Although many serious problems with misleading promotion persist,6 they are more subtle and thus less amenable to open-letter campaigns. To understand these problems better, we developed a stronger multidisciplinary team with expertise in medicine, marketing, psychology, pharmacy, pharmacology, statistics and logic.7

We were inspired to change our name to Healthy Skepticism by a 1963 speech from drug advertising executive Pierre Garai.8 Garai urged doctors to stop blaming drug companies for misleading drug promotion and argued that the quality of drug promotion depends on the quality of medical decision-making; “. . . indeed, [if] candor, accuracy, scientific completeness, and a permanent ban on cartoons came to be essential for the successful promotion of [prescription] drugs, advertising would have no choice but to comply”. Garai challenged doctors to accept responsibility for improving their decision-making and to develop healthy scepticism.

We accept that effective promotion is a mirror to our souls, reflecting how we really make decisions. The image it reveals differs from what we would prefer to believe about ourselves. However, accepting our human limitations is the best first step towards improved medical care. Consequently, we accept Garai’s challenge, but we feel that blaming the targets of promotion for human vulnerability to promotional techniques is not helpful. Many techniques have been effective in fooling many of the people much of the time for centuries;9 others are products of recent sophisticated research on ways to increase sales.10,11 We prefer to focus on changing the current system in which misleading promotion leads to inappropriate prescribing and higher profits for drug companies, thus funding more misleading promotion. This vicious cycle harms patients and may reduce incomes for doctors and drug companies in the long run.

The concept of healthy scepticism

There were two schools of extreme scepticism in ancient Greece. The Pyrrhonian Sceptics suspended judgement on all claims, including the Academic Sceptics’ claim that nothing could be known for certain. Moderate healthy scepticism started with the 16th century theologian Castellio, who advocated accepting reasonable beliefs rather than aiming for certainty.12

In the 1990s, a US business academic developed a questionnaire for measuring scepticism.13 She characterised sceptics as slow to accept claims or form judgements, but keen to ask questions in pursuit of knowledge and understanding, and found that sceptical auditors were more effective and efficient at detecting problems in company accounts.

Thus, healthy scepticism involves selectively accepting claims that are justified by good evidence or argument, while resisting those that are not.

Understanding misleading promotion

From Aristotle onward, logicians have observed many types of misleading arguments, which are now called fallacies.9 Psychologists have studied similar concepts, calling them heuristics, biases and influence techniques.14,15 We prefer the term shortcuts. These are quick and easy processes for reaching conclusions that are correct only when common assumptions are justified. For example, “newer is better” is usually a reliable shortcut for choosing the best vegetables or computers, but often unreliable when choosing drugs. It is common to assume that most new drugs are superior, but only about 3% of new drugs offer real advances.16 It is normal to use shortcuts when faced with inadequate time, skills or resources to examine the evidence fully, or when the evidence required is not available. Some common shortcuts are listed in the Box.

Drug companies are skilled at influencing prescribing by triggering the shortcuts that doctors rely on. For example, the “experts know best” shortcut underpins company-funded education. Drug companies also carefully choose visual and verbal images that appeal to our normal desires for power, respect, wealth, speed, simplicity, security and sex.10

There is evidence that advertising can be effective at influencing behaviour despite being given little attention.11 Subtle messages that might be rejected if carefully considered can sneak “under the radar” to create links between the indication, the product and the motivation. Repetition strengthens these links so that the product moves up the mental agenda to be the first to come to mind during decision-making.

Promotional techniques are tools for good or ill depending on how they are used and what they are used for. Shortcuts often lead to correct conclusions, and desires can be appropriate. It is not possible to advance good causes without using promotion. To be successful at advancing the aims of Healthy Skepticism, we have to use the same techniques that we want people to be more sceptical about. However, we aim to use promotion honestly. This article uses all the shortcuts listed in the Box and appeals to most of the desires listed above.

Developing healthy scepticism with AdWatch

Healthy scepticism is difficult to promote because most people are confident that they already have an optimal amount. It is common to believe that only other people are susceptible to being misled. Dispelling this illusion of unique invulnerability is the key to improving discrimination between misleading and justified claims.15 One effective method for dispelling this illusion is to mislead people and then show them how they have been deceived. In one study, hospital pharmacists used the techniques of drug company representatives to mislead medical students and then explained the techniques.17 After the intervention, the students were less certain about the value of interactions with drug company representatives.

We hope AdWatch will produce similar benefits by explaining the logical, psychological and pharmacological techniques used in drug advertisements. We will also use feedback from visitors to the AdWatch section of the Healthy Skepticism website (www.healthyskepticism.org/adwatch.asp) for dialogue with the companies responsible for the advertisements, the Medicines Australia Code of Conduct Committee and the government regulatory agencies.

We have started with advertisements targeting Australian general practitioners but hope to develop editions for specialists and for other countries. Initial feedback to AdWatch from general practitioners, specialists, pharmacists and members of the public worldwide has been positive. An Australian doctor commented: “Unfortunately [the advertisement] had me sucked in for a period, but no longer.”

Commonly used shortcuts for choosing therapies

  • Newer is better.

  • Experts know best.

  • If there is mechanism for how it works, it works.

  • If my peers are using a therapy, so should I.

  • If the manufacturers give gifts, I should support them in return.

  • If I see changes after prescribing a therapy, that therapy must be the cause.

Acknowledgements

AdWatch is based on an original suggestion from general practitioner Danny Csutoros. Its design was influenced by a survey of our subscribers, the Media Watch TV program and experiences with MaLAM and our Healthy Scepticism New Zealand newsletter.

Joel Lexchin, Jon Jureidini, Melissa Raven, Heather Carter, Rosie Burn, Danny Csutoros, Agnes Vitry, Michael Sorokin, Dianne Campbell, Tanya Wittwer, Chris Doecke and David Menkes contribute to Healthy Skepticism and commented on drafts of this article.

Subscribers and members of Healthy Skepticism are the only source of financial support for AdWatch. My PhD candidature is supported by the Department of General Practice, University of Adelaide, and a National Health and Medical Research Council Public Health Postgraduate Scholarship.

Competing interests

I have occasionally received payment for time from Healthy Skepticism Inc.

References
  1. Dukes MN. Accountability of the pharmaceutical industry. Lancet 2002; 360: 1682-1684. <PubMed>
  2. Lexchin J, Mansfield PR, Mintzes B, et al. Drug promotion database. World Health Organization Department of Essential Drugs and Medicines Policy, Health Action International Europe and Universiti Sains Malaysia. Available at: www.drugpromo.info (accessed Oct 2003).
  3. Sweet M. Website launched to expose “tricks” of drug ads. BMJ 2003; 327: 936.
  4. Mansfield PR. MaLAM, a medical lobby for appropriate marketing of pharmaceuticals. Med J Aust 1997; 167: 590-592. <eMJA full text> <PubMed>
  5. Mansfield PR. Classifying improvements to drug marketing and justifications for claims of efficacy. Int J Risk Safety Med 1991; 2: 171-184.
  6. Vlassov V, Mansfield PR, Lexchin J, Vlassova A. Do drug advertisements in Russian medical journals provide essential information for safe prescribing? West J Med 2001; 174: 391-394. <PubMed>
  7. Mansfield PR, Lexchin J, Vitry A, et al. Drug advertising in medical journals. Lancet 2003; 361: 879. <PubMed>
  8. Garai PR. Advertising and promotion of drugs. In: Talalay P, editor. Drugs in our society. Baltimore: Johns Hopkins Press, 1964.
  9. Hamblin CL. Fallacies. London: Methuen, 1970.
  10. Scott DK, Ferner RE. “The strategy of desire” and rational prescribing. Br J Clin Pharmacol 1994; 37: 217-219. <PubMed>
  11. Sutherland M. Advertising and the mind of the consumer: what works, what doesn’t and why. Sydney: Allen and Unwin, 1993: 189-202.
  12. Popkin RH. The history of scepticism: from Erasmus to Descartes. New York: Harper Torchbooks, 1964.
  13. Hurtt RK. Skeptical about skepticism: instrument development and experimental validation [dissertation]. Salt Lake City, Utah: University of Utah, 1999.
  14. Kahneman D, Slovic P, Tversky A. Judgment under uncertainty: heuristics and biases. New York: Cambridge University Press, 1982.
  15. Sagarin BJ, Cialdini RB, Rice WE, Serna SB. Dispelling the illusion of invulnerability: the motivations and mechanisms of resistance to persuasion. J Pers Soc Psychol 2002; 83: 526-541. <PubMed>
  16. A review of new drugs and indications in 2002: financial speculation or better patient care? Prescrire Int 2003; 12: 74-77. <PubMed>
  17. Wilkes MS, Hoffman JR. An innovative approach to educating medical students about pharmaceutical promotion. Acad Med 2001; 76: 1271-1277. <PubMed>

(Received 1 Oct 2003, accepted 3 Nov 2003)

Healthy Skepticism Inc, Willunga, SA.

Peter R Mansfield, BM BS, Director.

Reprints: Dr Peter R Mansfield, Healthy Skepticism Inc, 34 Methodist St, Willunga, SA 5172. peterAThealthyskepticism.org

AntiSpam note: To avoid attracting spam mail robots, authors' email addresses on the MJA website are written with AT in place of the usual symbol, and we have removed "mail to" links. Replace AT with the correct symbol to get a valid address. We regret the inconvenience this entails. Lobby your government for more effective antispam regulations.

©The Medical Journal of Australia 2003 www.mja.com.au ISSN: 0025-729X

Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA